ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Papa Medical's annualized net income for the quarter that ended in Mar. 2025 was $3.16 Mil. Papa Medical's average Total Stockholders Equity over the quarter that ended in Mar. 2025 was $3.37 Mil. Therefore, Papa Medical's annualized ROE % for the quarter that ended in Mar. 2025 was 93.55%.
The historical rank and industry rank for Papa Medical's ROE % or its related term are showing as below:
PAPA's ROE % is not ranked *
in the Tobacco Products industry.
Industry Median: 16.13 * Ranked among companies with meaningful ROE % only.
Papa Medical (NAS:PAPA) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2025) net income data. The Revenue data used here is four times the quarterly (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Papa Medical ROE % Related Terms
Papa Medical ROE % Historical Data
* Premium members only.
The historical data trend for Papa Medical's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Tobacco subindustry, Papa Medical's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Papa Medical ROE % vs Tobacco Products Industry
For the Tobacco Products industry and Consumer Defensive sector, Papa Medical's ROE % distribution charts can be found below:
* The bar in red indicates where Papa Medical's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Papa Medical (PAPA) has a ROE % of 93.55% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Papa Medical and its competitors.
Is Papa Medical's ROE % too high?
Papa Medical's current ROE % is 93.55%. The Tobacco Products industry median ROE % is 16.13. Papa Medical's value of 93.55% is 480% above this industry median.
How does Papa Medical's ROE % compare to ?
Papa Medical's ROE % of 93.55% can be compared against companies in the Tobacco Products industry. The industry median ROE % is 16.13. Papa Medical's value of 93.55% is 480% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Tobacco Products company?
The median ROE % among Tobacco Products companies is 16.13, based on 45 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Papa Medical's current ROE % of 93.55% is 480% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Papa Medical and its competitors. For the Tobacco Products industry, the median ROE % is 16.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Papa Medical's current ROE % is 93.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current ROE % of 93.55%. The current ROE % is 93.55% and 480% above the Tobacco Products industry median of 16.13. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Papa Medical (PAPA), the current ROE % is 93.55% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PAPA has been successfully added to your 